BDC

BIS-(9-OCTYLAMINO(2-DIMETHYLAMINOETHYL)ACRIDINE-4-CARBOXAMIDE

Created:	2001-10-12
Last modified:	2021-03-01

Find Related PDB Entry
1 entries where BDC is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	108
Chiral Atom Count	0
Bond Count	113
Aromatic Bond Count	32

2D diagram of BDC

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	BIS-(9-OCTYLAMINO(2-DIMETHYLAMINOETHYL)ACRIDINE-4-CARBOXAMIDE
Synonyms	BIS-DACA
Systematic Name (OpenEye OEToolkits)	N-(2-dimethylaminoethyl)-9-[8-[[4-(2-dimethylaminoethylcarbamoyl)acridin-9-yl]amino]octylamino]acridine-4-carboxamide
Formula	C₄₄ H₅₄ N₈ O₂
Molecular Weight	726.952
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(NCCN(C)C)c3c2nc1c(cccc1)c(c2ccc3)NCCCCCCCCNc4c6c(nc5c4cccc5C(=O)NCCN(C)C)cccc6
SMILES	CACTVS	3.341	CN(C)CCNC(=O)c1cccc2c(NCCCCCCCCNc3c4ccccc4nc5c(cccc35)C(=O)NCCN(C)C)c6ccccc6nc12
SMILES	OpenEye OEToolkits	1.5.0	CN(C)CCNC(=O)c1cccc2c1nc3ccccc3c2NCCCCCCCCNc4c5ccccc5nc6c4cccc6C(=O)NCCN(C)C
Canonical SMILES	CACTVS	3.341	CN(C)CCNC(=O)c1cccc2c(NCCCCCCCCNc3c4ccccc4nc5c(cccc35)C(=O)NCCN(C)C)c6ccccc6nc12
Canonical SMILES	OpenEye OEToolkits	1.5.0	CN(C)CCNC(=O)c1cccc2c1nc3ccccc3c2NCCCCCCCCNc4c5ccccc5nc6c4cccc6C(=O)NCCN(C)C
InChI	InChI	1.03	InChI=1S/C44H54N8O2/c1-51(2)29-27-47-43(53)35-21-15-19-33-39(31-17-9-11-23-37(31)49-41(33)35)45-25-13-7-5-6-8-14-26-46-40-32-18-10-12-24-38(32)50-42-34(40)20-16-22-36(42)44(54)48-28-30-52(3)4/h9-12,15-24H,5-8,13-14,25-30H2,1-4H3,(H,45,49)(H,46,50)(H,47,53)(H,48,54)
InChIKey	InChI	1.03	UUXARTGDSXDSRM-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	3465282
ChEMBL	CHEMBL345599

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.